Global Lead Auditor Services: Ensuring Supplier Quality in Bio-Pharma & Medical Device Supply Chains

Global Supplier Auditing and Compliance by IRCA Certified Expert Eran Yona

 

The Bottom Line for Procurement and Sourcing Directors
Your supply chain is a legal and financial liability if not verified by boots on the ground expertise. Relying on vendor questionnaires is a high risk strategy that often leads to FDA Warning Letters or costly recalls. Engaging an IRCA registered and NSF certified Lead Auditor like Eran Yona ensures your vendors meet the Gold Standard of FDA EMA and ISO compliance. This reduces your time to market eliminates international travel costs and secures your regulatory standing before a single product is shipped.

For procurement managers and sourcing directors the integrity of the supply chain is only as strong as its weakest link.

Eran Yona is an IRCA registered and NSF certified Lead Auditor based in Israel providing expert second party and third party audits worldwide. With over 20 years of experience and 1000 plus projects led for giants like Teva Merck and Johnson and Johnson Eran ensures that your supplier quality meets the most stringent FDA EMA and ISO standards.

Why Global Procurement and Sourcing Teams Need Certified Auditing

When a recruiter or sourcing specialist brings a new vendor into the supply chain the risk of regulatory non compliance is high. Moreover based on the current regulatory requirements approved suppliers must be audited periodically for re approval. Relying on a questionnaire and quality agreement is not enough to guarantee supplier quality. Professional on site and remote auditing verifies that vendors actually follow the SOPs they have on paper.

Auditing Capabilities at a Glance

Eran Yona provides independent auditing services across pharmaceutical, biotechnology, medical device, clinical research and digital health sectors. Audits are tailored to the supplier’s activities, applicable regulatory frameworks, agreed audit criteria and identified risks. The following table summarizes the principal auditing capabilities.

Audit Type Regulatory Standards Covered Key Focus Areas
Pharmaceutical EU GMP Part I and II, ICH Q7, 21 CFR 210-211 DS/API, Finished Products, Sterile Manufacturing
Medical Device ISO 13485, MDSAP, EU MDR, 21 CFR Part 820 (FDA QMSR) Design Control, Validation, Sterilization, Assembly
Digital Health ISO 27001, HIPAA, GDPR, Annex 11 Cybersecurity, Software Validation, Data Integrity
Supply Chain GDP Good Distribution Practice Storage, Transportation, Cold Chain Integrity

Additional GxP and Digital Health Auditing Capabilities

In addition to the auditing services summarized above, Eran Yona conducts GCP audits of clinical research activities, GLP audits of nonclinical laboratory operations, and GDP audits of pharmaceutical distribution activities, according to the applicable requirements and agreed scope.

Digital Health and Software as a Medical Device (SaMD) audits may include ISO 13485 quality systems, IEC 62304 software lifecycle processes, ISO 14971 risk management, software verification and validation, and relevant cybersecurity controls.

Independent assessments against applicable MDSAP requirements may also support supplier qualification and audit readiness. Such assessments do not constitute official MDSAP certification audits performed by recognized Auditing Organizations.

Audit Findings, Supplier CAPA and Effectiveness Follow-Up

An independent audit evaluates objective evidence against the agreed audit criteria and documents findings, including identified nonconformities and areas requiring further attention.

The audited supplier is generally responsible for investigating nonconformities, determining root causes, preparing corrective and preventive actions (CAPA), and implementing appropriate improvements.

Where included in the engagement, the auditor may review the proposed CAPA plan, evaluate supporting evidence and perform follow-up assessments to determine whether corrective actions have been implemented effectively.

The scope of CAPA-related support and follow-up activities should be agreed in advance, with appropriate consideration of auditor independence and potential conflicts of interest.

Strategic Advantages of a Local Lead Auditor in Israel

For international life-science companies working with Israeli suppliers, appointing an experienced local auditor can offer significant logistical and operational advantages.

Local availability can reduce international travel requirements, facilitate communication in Hebrew and English, simplify audit scheduling and enable on-site assessments and follow-up activities.

Auditor selection should be based on relevant technical expertise, demonstrated experience, professional qualifications, independence and the requirements of the specific engagement.

An independent audit supports risk-based supplier oversight and informed quality decisions. It does not guarantee the outcome of a regulatory inspection or future compliance.


Frequently Asked Questions

Can you help a procurement manager qualify a new vendor?
Yes. I conduct independent supplier qualification and due diligence audits for international life-science companies. The assessment may include the supplier’s quality management system, facilities, manufacturing or service processes, documentation and applicable regulatory requirements. Audit findings support the client’s risk-based supplier approval and oversight decisions.

What happens if a supplier fails the audit?
Nonconformities are documented and classified according to the agreed audit criteria. The supplier is generally responsible for investigating the findings, identifying root causes and implementing appropriate corrective actions. Where included in the engagement, I may review the supplier’s CAPA responses and assess evidence of implementation and effectiveness. The commissioning company determines the supplier’s approval status.

Do you conduct remote audits?

Yes. Remote audits may be appropriate for selected quality management systems, documentation, computerized systems and software-related processes. Their suitability depends on the audit objectives, applicable requirements, available evidence and associated risks. On-site assessment may be necessary when direct observation of facilities, equipment or manufacturing activities is important.

Where do you conduct audits?
I am based in Israel and provide on-site auditing services for international companies that need to assess Israeli suppliers, manufacturers, laboratories, clinical research organizations and digital health companies. Auditing engagements in other countries may also be considered according to the required scope and availability.

Can an international company hire a local auditor to assess a supplier in Israel?

Yes. International pharmaceutical, biotechnology, medical device and digital health companies can appoint an independent Israel-based auditor to assess their local suppliers without sending their own audit team overseas.

Depending on the agreed scope, the audit may address GMP, GDP, GLP, GCP, ISO 13485, relevant MDSAP requirements or software-related quality processes. The assessment is documented in an evidence-based audit report to support supplier qualification and oversight decisions.


Contact Eran Yona for Auditing Services

Need an independent auditor for a supplier or regulated facility in Israel?

Contact Eran Yona to discuss your audit objectives, applicable requirements, proposed schedule and reporting needs.

Request an Audit in Israel

Explore Lead Auditor Services in Israel

Scroll to Top
Skip to content